| PLUS THERAPEUTICS |
| USA |
| Gesundheit |
| US72941H5090 / A3EEZB |
| XMP0 (Frankfurt) / PSTV (NASDAQ) |
| FRA:XMP0, ETR:XMP0, XMP0:GR, NASDAQ:PSTV |
| - |
| https://plustherapeutics... |
|
Plus Therapeutics Inc. is a clinical-stage pharmaceutical company focused on developing innovative, targeted radiotherapeutics for adults and children with difficult-to-treat cancers, particularly those of the central nervous system. Its lead product..
>Volltext.. |
| 529.08 Mio. EUR |
| 518.43 Mio. EUR |
| 4.52 Mio. EUR |
| -12.87 Mio. EUR |
| -22.82 Mio. EUR |
| -1.08 EUR |
| 0.71 Mio. EUR |
| 7.59 Mio. EUR |
| -18 Mio. EUR |
| 1.06 |
| -10.49% |
| -103.01% |
| - |
| - |
| - |
| - |
| PLUS THERAPEUTICS, PLUS THERAPEUTIC |
| 05.04.26 |
|
||||
|
||||
|